Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1861-1870 of 2933 for cancer

Edit search filters
  1. Phase III Open Label First Line Therapy Study Of MEDI 4736 (Durvalumab) With Or Without Tremelimumab Versus SOC In Non Small-Cell Lung Cancer (NSCLC).

    Scottsdale/Phoenix, AZ

  2. A Study Comparing Gemcitabine With Or Without AZD 1775 In Treating Patients With Recurrent Ovarian, Primary Peritoneal, Or Fallopian Tube Cancer

    Rochester, MN

  3. Suppression Of Ovarian Function With Either Tamoxifen Or Exemestane Compared With Tamoxifen Alone In Treating Premenopausal Women With Hormone-Responsive Breast Cancer

    Eau Claire, WI

  4. A Study Of Rucaparib In Patients With Platinum-Sensitive, Relapsed, High-Grade Epithelial Ovarian, Fallopian Tube, Or Primary Peritoneal Cancer (ARIEL2)

    Jacksonville, FL, Rochester, MN

  5. COlorectal Cancer Treated With Adjuvant Regorafenib Versus Placebo After Curative Treatment Of Liver Metastases In A Randomized, Double-blind, Placebo‑Controlled Phase-III STudy

    Rochester, MN

  6. Trametinib, Combination Chemotherapy, And Radiation Therapy In Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed By Surgery

    Rochester, MN

  7. Phase III Open Label Study Of MEDI 4736 With/Without Tremelimumab Versus Standard Of Care (SOC) In Recurrent/Metastatic Head And Neck Cancer

    Rochester, MN

  8. A Study Evaluating Safety And Efficacy Of Venetoclax In Combination With Azacitidine Versus Standard Of Care After Allogeneic Stem Cell Transplantation (SCT) In Participants With Acute Myeloid Leukemia (AML)

    Jacksonville, FL, Rochester, MN

  9. Study Of Safety And Efficacy Of Dapagliflozin + Metformin XR Versus Metformin XR In Participants With HR+, HER2-, Advanced Breast Cancer While On Treatment With Alpelisib And Fulvestrant

    Jacksonville, FL, Rochester, MN

  10. Dose Escalation And Double-blind Study Of Veliparib In Combination With Carboplatin And Etoposide In Treatment-naive Extensive Stage Disease Small Cell Lung Cancer

    Scottsdale/Phoenix, AZ

.

Mayo Clinic Footer